Search
for
Sort by
Research 211–240 of 1000+
- Anti-Androgenic Potential of Plant Extracts: Molecular Mechanisms, Synergistic Effects, and Nutritional Interventions
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- BPH: epidemiology and comorbidities.
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
- 5alpha-reductase: history and clinical importance.
- Association of Benign Prostatic Hyperplasia with Male Pattern Baldness
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- PNU 157706, a novel dual type I and II5α-reductase inhibitor
- Effect of a novel steroid (PM-9) on the inhibition of 5α-reductase present in Penicillium crustosum broths
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- The Role of Non-Aromatizable Testosterone Metabolite in Metabolic Pathways
- Potential Medical Uses of Cannabigerol: A Brief Overview
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
- The Conception and Evaluation of Sexual Health Literature
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Melasma and Endocrine Disorders
- Androgenic alopecia--Its characteristics and perspectives
- Hemorrhagic Cystitis in Allogeneic Stem Cell Transplantation: A Role for Age and Prostatic Hyperplasia
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Androstenedione
- Oral administration of low-dose bisphenol A promotes proliferation of ventral prostate and upregulates prostaglandin D<sub>2</sub> synthase expression in adult rats
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates